Clinical Trial: Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin

Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional




Official Title: An Open Label, Multicenter, Single Arm Study of Pasireotide LAR in Patients With Rare Tumors of Neuroendocrine Origin

Brief Summary: This study will assess the effectiveness and safety of pasireotide long-acting release in patients who have rare tumors of neuroendocrine origin.